Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_provenance.
- NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_assertion description "[Hybrids formed by fusion of either human acute lymphoblastic or chronic lymphocytic leukemia cells and the mouse myeloma P3.X63.Ag8/653 have been used to show that the expression of two cell surface antigens, Bp37 and p76, associated with B cell activation and detected by the monoclonal antibodies BB1 and BB2, respectively, segregate with human chromosomes 12 and 19, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_provenance.
- NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_assertion evidence source_evidence_literature NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_provenance.
- NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_assertion SIO_000772 3871395 NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_provenance.
- NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_assertion wasDerivedFrom befree-2016 NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_provenance.
- NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_assertion wasGeneratedBy ECO_0000203 NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1303895.RA5Fc7xZIF4pMK-hteExxpdDadDCI-ObKIQO_JJBMtkrQ130_provenance.